|
| 4¿ù 30ÀÏ(±Ý) |
Updated Clinical Guideline¥° |
| 08:20~09:50 |
°©»ó¼± °áÀý ¹× ºÐȾϿ¡ ´ëÇÑ revised ATA guidelines |
Á¶¿µ¼®(Ãæ³²ÀÇ´ë, ³»ºÐºñ³»°ú) |
| Management of thyroid dysfunction during pregnancy and postpartum |
¹Ú¹Ì°æ(µ¿¾ÆÀÇ´ë, ³»ºÐºñ³»°ú) |
| Management of adrenal incidentaloma |
ÀÌÀçÇõ(À»ÁöÀÇ´ë, ³»ºÐºñ³»°ú) |
| 16:30~18:00 |
Updated Clinical Guideline II |
| ´ç´¢º´, ´ç´¢º´Àü´Ü°è ¹× Àӽżº ´ç´¢º´ÀÇ »õ·Î¿î Áø´Ü ±âÁØ |
±è¼ö°æ(CHAÀǰúÇдëÇб³, ³»ºÐºñ³»°ú) |
| ´ç´¢º´È¯ÀÚ¿¡¼ÀÇ primary ¹× secondary prevention ¸ñÀûÀÇ antiplatelet therapy |
±èÇýÁø(¾ÆÁÖÀÇ´ë, ³»ºÐºñ³»°ú) |
| Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient |
ÇãÀ±¼®(ÀÎÇÏÀÇ´ë, ¿Ü°ú) |
|
| 5¿ù 1ÀÏ(Åä) |
Updated Clinical Guideline ¥² |
| 08:20~09:50 |
Male osteoporosis |
±è»ó¿í(°¿øÀÇ´ë, ³»ºÐºñ³»°ú) |
| Primary and secondary hyperparathyroidism |
°í°üÇ¥(Á¦ÁÖÀÇ´ë, ³»ºÐºñ³»°ú) |
| Evaluation for amenorrhea |
Á¶½ÃÇö(¿¬¼¼ÀÇ´ë, »êºÎÀΰú) |
| 16:40~17:40 |
Updated Clinical Guideline IV |
| Polycystic ovary syndrome and therapeutic options |
±èÁøÁÖ(¼¿ïÀÇ´ë, »êºÎÀΰú) |
| Hypertriglyceridemia: clinical guideline |
¾Èö¿ì(¿¬¼¼ÀÇ´ë, ³»ºÐºñ³»°ú) |